MDxHealth (MDXH) Gains from Investment Securities (2021 - 2022)

MDxHealth has reported Gains from Investment Securities for 4 years, with the latest figure at $44.8 million in Q2 2025.

• Quarterly Gains from Investment Securities fell 29.86% year-over-year to $44.8 million in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $44.8 million (down 29.86% YoY) and the FY2025 annual result came in at $44.8 million, changed N/A from the prior year.
• Gains from Investment Securities declined to $44.8 million in Q2 2025 per MDXH's latest filing, from $67.3 million in the prior quarter.
• Over five years, Gains from Investment Securities peaked at $67.3 million in Q4 2024 and troughed at $44.8 million in Q2 2025.
• A 4-year average of $58.2 million and a median of $60.1 million in 2023 frame the typical range for Gains from Investment Securities.
• The sharpest annual moves came in 2023 and 2025: Gains from Investment Securities advanced 18.4% in 2023, then fell 29.86% in 2025.
• Over 4 years, Gains from Investment Securities stood at $52.9 million in 2022, then advanced by 18.4% to $62.6 million in 2023, then grew by 7.46% to $67.3 million in 2024, then sank by 33.41% to $44.8 million in 2025.
• According to Business Quant data, Gains from Investment Securities over the past three periods registered $44.8 million, $67.3 million, and $63.9 million for Q2 2025, Q4 2024, and Q2 2024 respectively.